Duchenne dystrophy affecting 1 in 3500 boys and there is no cure or therapy but our company has a patented orphan drug. Gsmtx4 is a peptide inhibits mechanosensitive ion channels activated only by pathologic stress. It is a unique peptide, non toxic to animals, and is currently undergoing preclinical trials. It has demonstrated applications beyond dystrophy including atrial fibrillation, incontinence and sickle cell anemia.